Key result
Anticoagulant therapy for deep vein thrombosis during pregnancy remains challenging due to potential maternal side effects from heparins and fetal risks from warfarin, alongside limited efficacy data.
This review highlights the challenges in diagnosing and treating DVT during pregnancy, noting the risks of standard anticoagulants and providing recommendations for management.
No takes yet. Share an insight, caveat, or question.
DVT anticoagulation in pregnancy warrants individualized risk assessment; leaves open need for prospective trials on safer regimens.
Bates et al. (2001) conducted a review in Deep vein thrombosis during pregnancy. Anticoagulant therapy was evaluated. Anticoagulant therapy for deep vein thrombosis during pregnancy remains challenging due to potential maternal side effects from heparins and fetal risks from warfarin, alongside limited efficacy data.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: